NAICS UNIVERSITY · Free research for insurance agents
Medicinal and Botanical Manufacturing
NAICS 325411 · United States · 2022 edition
This U.S. industry comprises establishments primarily engaged in (1) manufacturing uncompounded medicinal chemicals and their derivatives (i.e., generally for use by pharmaceutical preparation manufacturers) and/or (2) grading, grinding, and milling uncompounded botanicals.
Start the review with product liability.
For Medicinal and Botanical Manufacturing, the saved research highlights product liability, environmental / pollution, employee injury. Confirm how these arise in the actual operation, what controls are used and whether additional services change the proposed coverage.
Questions to ask
- What specific products are manufactured — botanical milling only, or does the operation involve chemical synthesis or derivatization?
- What is the downstream use of the output — pharmaceutical manufacturers, nutraceutical formulators, other industrial users?
- What solvents, reagents, or reactive chemicals are used on-site, and in what quantities?
- Does the operation hold any GMP certification, ISO certification, or conduct third-party quality testing?
- Any prior FDA inspections, warning letters, or regulatory enforcement history?
- Are there any known environmental issues, prior spills, or remediation activity at the facility?
- For Medicinal and Botanical Manufacturing, what should the underwriter know about synthesis or derivatization of controlled substance precursors or dea-scheduled compounds?
- For Medicinal and Botanical Manufacturing, what should the underwriter know about prior product liability losses, fda warning letters, or regulatory enforcement actions?
Activities described by this code
Other activities to examine
- Manufacturing packaged compounded medicinals and botanicals: 325412 — Pharmaceutical Preparation Manufacturing;
- Manufacturing vaccines, toxoids, blood fractions, and culture media of plant or animal origin (except for diagnostic use): 325414 — Biological Product (except Diagnostic) Manufacturing
Census classification reference
For educational purposes only. AI-generated insurance research and automated logic can contain errors. Independently verify classification and coverage decisions.
Compare another operationInsurance operations research — draft
Establishments in this class manufacture uncompounded medicinal chemicals and derivatives — often as intermediate inputs for pharmaceutical preparation manufacturers — or grade, grind, and mill uncompounded botanicals. Day-to-day operations may involve chemical extraction, distillation, solvent use, drying, milling, and quality-control testing. Output typically feeds downstream formulators, supplement manufacturers, or pharmaceutical producers rather than end consumers directly.
Questions to investigate
- What specific products are manufactured — botanical milling only, or does the operation involve chemical synthesis or derivatization?
- What is the downstream use of the output — pharmaceutical manufacturers, nutraceutical formulators, other industrial users?
- What solvents, reagents, or reactive chemicals are used on-site, and in what quantities?
- Does the operation hold any GMP certification, ISO certification, or conduct third-party quality testing?
This insurance research was generated in April 2026. It has not received a complete human review. The October 12, 2026 audit checked codes and titles only, not descriptions or coverage assertions.